3rd COVID shot "likely" needed within 12 months

The CEO of Pfizer said a booster shot will likely be needed within 12 months of being fully vaccinated. Mola Lenghi has the latest.

• Apr 15, 2021

The Price of Generics, The Most Unlikely Meeting, Mark Bradford

Sweeping lawsuit accuses top generic drug companies, executives of fixing prices; then, crime victims get chance to confront perpetrators through special program; and, Anderson Cooper profiles Mark Bradford, the artist who tackles complex social and political issues through abstract works

• May 12, 2019
• 43:18

New study may shed light on COVID blood clots

Research from Oxford University in England has new data regarding the rate of blood clotting cases in COVID-19 patients and vaccine recipients. The study, which has not been peer-reviewed yet, shows that the particular blood clot which was studied is eight to ten times more common in people who experience a COVID-19 infection than in people who were inoculated. Dr. David Agus joins "CBS This Morning" to explain the latest development.

• Apr 15, 2021
• 02:19

CDC holds emergency vaccine meeting

The FDA and CDC are trying to determine whether the Johnson and Johnson vaccine is linked to a handful of blood clotting cases, one of them fatal. Tanya Rivero spoke with John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, about the new concerns.

• Apr 14, 2021
• 08:03

Study raises questions over vaccine effectiveness

Findings from a new study in Israel suggest Pfizer's vaccine was less effective at offering protection against the coronavirus variant first detected in South Africa. Carl Zimmer, the New York Times "Matter" columnist and award-winning science writer, joins CBSN's "Red & Blue" to explain why people should get vaccinated anyway.

• Apr 12, 2021
• 07:15

Ford halts use of Takata airbags, Pfizer's merger with Allergan prompts bipartisan criticism, Costco says no to genetically modified salmon and more. CBS News Moneywatch's Jill Wagner has today's CBSN business headlines.

Ford halts use of Takata airbags, Pfizer's merger with Allergan prompts bipartisan criticism, Costco says no to genetically modified salmon and more

• Nov 24, 2015
• 01:14

Drugmakers Pfizer and Allergan are close to a historic merger, Thanksgiving gas prices are at their lowest since 2008 and more

Drugmakers Pfizer and Allergan are close to a historic merger, Thanksgiving gas prices are at their lowest since 2008 and more. CBS News Moneywatch's Jill Wagner has today's CBSN business headlines.

• Nov 23, 2015
• 01:09

Reports of adverse reactions to Johnson & Johnson COVID vaccine

Georgia has become the latest state to temporarily shut down a vaccination site after multiple people reported adverse reactions to the Johnson and Johnson COVID-19 vaccine. Pfizer has asked the FDA to expand emergency use of its COVID-19 vaccine to adolescents, as cases spike in children. CBS News researcher Max Bayer joins CBSN to discuss.

• Apr 10, 2021
• 08:25

Children are in the spotlight in the coronavirus battle

Pfizer wants to extend its COVID-19 vaccine to those as young as 12 years old and has asked the FDA for authorization to do that.

• Apr 10, 2021

The Federal Reserve declines to raise interest rates, Pfizer and Allergan consider combining, Americans buy less candy and more

The Federal Reserve declines to raise interest rates, Pfizer and Allergan consider combining, Americans buy less candy and more. CBS News Moneywatch's Jill Wagner has today's CBSN business headlines.

• Oct 29, 2015
• 01:10

"Vaccine passports" spark debate and division

Multiple companies are developing vaccine passport apps as proof of immunization against the coronavirus, but whether they can be legally required is up for debate. Adriana Diaz has more.

• Apr 7, 2021
• 02:09

Pfizer and BioNTech: Vaccine is 91% effective against COVID-19

Only a handful of people who got the drugmakers' vaccine contracted coronavirus, according to the latest trial.

• Apr 1, 2021

Pfizer says its COVID vaccine 100% effective in 12- to 15-year-olds

The results are seen as a step toward possibly beginning shots in that age group before they head back to school in the fall.

• Mar 31, 2021

Pfizer says COVID vaccine effective for kids

In a study of more than 2,200 kids between 12 and 15 years old, Pfizer found that its COVID-19 vaccine is fully effective and safe. Dr. Susannah Hills spoke with Anne-Marie Green and Vladimir Duthiers on CBSN about what this study means for school reopenings and herd immunity in the U.S.

• Mar 31, 2021
• 06:48

Kids' vaccine trial & info possible side effect

Pfizer announced it has started testing its COVID-19 vaccine on children under 12 years old. Dr. Bob Lahita spoke with Anne-Marie Green and Vladimir Duthiers on CBSN about what researchers are looking for. He also explained how some people experience swollen lymph nodes as a side-effect from vaccination, which could be mistaken for a sign of breast cancer, and what you need to know before you go in for a mammogram.

• Mar 26, 2021
• 08:06

At least 20 states report rise in COVID cases

President Biden has set a new goal of administering 200 million coronavirus vaccine doses by the end of April. It comes as at least 20 states are reporting a rise in new cases. As CBS News' Mola Lenghi reports, officials say the variant first found in the U.K. may be to blame. Then, Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital, joins CBSN's Lana Zak with his insight.

• Mar 25, 2021
• 07:45

Trial mixing-and-matching COVID-19 vaccines could be a game-changer

Scientists behind an Oxford University-led trial in the U.K. say the results could help address both vaccine shortages, and worrying coronavirus variants.

• Mar 23, 2021

"CBS This Morning" takes a look at some of the headlines from around the globe

"CBS This Morning" takes a look at some of the headlines from around the globe.

• May 19, 2014
• 00:54

Rural communities struggle with access to vaccination sites

Vaccine distribution efforts in the U.S. are ramping up. President Biden has promised enough doses for all adults by the end of May. Part of the plan to reach that goal is to make the shots available at more than 20,000 pharmacies nationwide. But access to physical pharmacies is not an option for many people, particularly those who live in rural areas. Dr. Michael Hogue, dean of the School of Pharmacy at Loma Linda University and president of the American Pharmacists Association, joined CBSN's Elaine Quijano to discuss.

• Mar 19, 2021
• 05:59

Europe resumes AstraZeneca vaccinations

Countries across Europe are back to administering the AstraZeneca vaccine after questions were raised about its safety. Chris Livesay reports.

• Mar 19, 2021
• 01:29

U.S. races to distribute COVID vaccine

President Biden is on track to beat his goal of 100 million COVID shots administered in his first 100 days. But cases are surging in more than a dozen states. Nikki Battiste reports.

• Mar 18, 2021
• 02:32

Pfizer execs discuss hiking vaccine price after pandemic wanes

A partnership with the government allowed Americans to receive the vaccine for free, but, according to Pfizer, does not mean the federal government helped fund its creation.

• Mar 17, 2021

How Facebook plans to inform about vaccines

Facebook Chief Product Officer Chris Cox explains how the tech firm will amplify authoritative information about coronavirus vaccines.

• Mar 16, 2021
• 00:48

Doctors say vaccine side effects are normal

Ahead of the anticipated distribution of the two-dose coronavirus vaccines from Moderna and Pfizer, medical experts are stressing the importance of getting the shots, and they say patients shouldn't be deterred by the possibility of minor side effects. Dr. Dara Kass joins CBSN to discuss the latest.

• Dec 4, 2020
• 06:11

Doctor on Biden's pandemic response

In his first prime-time address since taking office, President Biden announced he is directing states to make COVID vaccines available to everyone 18 and older by May 1. He also said the U.S. could see a return to some sort of normalcy by the Fourth of July. Dr. Bob Lahita spoke with CBSN's Anne-Marie Green and Vladimir Duthiers about the president's address and concerns about the variants that continue to spread.

• Mar 12, 2021
• 07:08

Show More